Literature DB >> 28092099

Calmodulin Binding to Death Receptor 5-mediated Death-Inducing Signaling Complex in Breast Cancer Cells.

Romone M Fancy1, Harrison Kim2, Tong Zhou3, Kurt R Zinn2, Donald J Buchsbaum4, Yuhua Song1.   

Abstract

Activation of death receptor-5 (DR5) leads to the formation of death-inducing signaling complex (DISC) for apoptotic signaling. TRA-8, a DR5 specific agonistic antibody, has demonstrated significant cytotoxic activity in vitro and in vivo without inducing hepatotoxicity. Calmodulin (CaM) that is overexpressed in breast cancer plays a critical role in regulating DR5-mediated apoptosis. However, the mechanism of CaM in regulating DR5-mediated apoptotic signaling remains unknown. In this study, we characterized CaM binding to DR5-mediated DISC for apoptosis in TRA-8 sensitive breast cancer cell lines using co-immunoprecipitation, fluorescence microscopic imaging, caspase signaling analysis, and cell viability assay. Results show that upon DR5 activation, CaM was recruited into DR5-mediated DISC in a calcium dependent manner. CaM antagonist, trifluoperazine (TFP), inhibited CaM recruitment into the DISC and attenuated DISC formation. DR5 oligomerization is critical for DISC formation for apoptosis. TFP decreased TRA-8 activated DR5 oligomerization, which was consistent with TFP's effect on DR5-mediated DISC formation. TFP and Ca2+ chelator, EGTA, impeded TRA-8-activated caspase-dependent apoptotic signaling, and TFP decreased TRA-8-induced cell cytotoxicity. These results demonstrated CaM binding to DR5-mediated DISC in a calcium dependent manner and may identify CaM as a key regulator of DR5-mediated DISC formation for apoptosis in breast cancer. J. Cell. Biochem. 118: 2285-2294, 2017.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  APOPTOSIS; BREAST CANCER CELLS; CALMODULIN; DEATH RECEPTOR 5; DISC; DR5 OLIGOMERIZATION

Mesh:

Substances:

Year:  2017        PMID: 28092099      PMCID: PMC5462859          DOI: 10.1002/jcb.25882

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  46 in total

1.  TRAIL activates acid sphingomyelinase via a redox mechanism and releases ceramide to trigger apoptosis.

Authors:  C A Dumitru; E Gulbins
Journal:  Oncogene       Date:  2006-04-24       Impact factor: 9.867

2.  Characterization of the interactions between calmodulin and death receptor 5 in triple-negative and estrogen receptor-positive breast cancer cells. AN INTEGRATED EXPERIMENTAL AND COMPUTATIONAL STUDY.

Authors:  Romone M Fancy; Lingyun Wang; Thomas Schmid; Qinghua Zeng; Hong Wang; Tong Zhou; Donald J Buchsbaum; Yuhua Song
Journal:  J Biol Chem       Date:  2016-11-04       Impact factor: 5.157

3.  Detection of Fas-associated death domain and its variants' self-association by fluorescence resonance energy transfer in living cells.

Authors:  Sheng Wang; Yuan Chen; Qiong Wu; Zi-Chun Hua
Journal:  Mol Imaging       Date:  2013 Mar-Apr       Impact factor: 4.488

Review 4.  Caspase-containing complexes in the regulation of cell death and inflammation.

Authors:  Nele Festjens; Sigrid Cornelis; Mohamed Lamkanfi; Peter Vandenabeele
Journal:  Biol Chem       Date:  2006-08       Impact factor: 3.915

5.  A study of calmodulin and its interaction with trifluoperazine by high resolution 1H NMR spectroscopy.

Authors:  R E Klevit; B A Levine; R J Williams
Journal:  FEBS Lett       Date:  1981-01-12       Impact factor: 4.124

Review 6.  The kiss of death: promises and failures of death receptors and ligands in cancer therapy.

Authors:  P T Daniel; T Wieder; I Sturm; K Schulze-Osthoff
Journal:  Leukemia       Date:  2001-07       Impact factor: 11.528

7.  Calmodulin inhibition contributes to sensitize TRAIL-induced apoptosis in human lung cancer H1299 cells.

Authors:  Mi-kyung Hwang; Yong Ki Min; Seong Hwan Kim
Journal:  Biochem Cell Biol       Date:  2009-12       Impact factor: 3.626

8.  Identification of an antiapoptotic protein complex at death receptors.

Authors:  M Sun; L Song; Y Li; T Zhou; R S Jope
Journal:  Cell Death Differ       Date:  2008-10-10       Impact factor: 15.828

9.  Trifluoperazine-induced conformational change in Ca(2+)-calmodulin.

Authors:  M Vandonselaar; R A Hickie; J W Quail; L T Delbaere
Journal:  Nat Struct Biol       Date:  1994-11

10.  Calmodulin antagonists promote TRA-8 therapy of resistant pancreatic cancer.

Authors:  Kaiyu Yuan; Sun Yong; Fei Xu; Tong Zhou; Jay M McDonald; Yabing Chen
Journal:  Oncotarget       Date:  2015-09-22
View more
  5 in total

1.  Calmodulin antagonist enhances DR5-mediated apoptotic signaling in TRA-8 resistant triple negative breast cancer cells.

Authors:  Romone M Fancy; Harrison Kim; Tiara Napier; Donald J Buchsbaum; Kurt R Zinn; Yuhua Song
Journal:  J Cell Biochem       Date:  2018-04-16       Impact factor: 4.429

2.  Screening and identification of potential biomarkers and therapeutic drugs in melanoma via integrated bioinformatics analysis.

Authors:  Bo Chen; Donghong Sun; Xiuni Qin; Xing-Hua Gao
Journal:  Invest New Drugs       Date:  2021-01-26       Impact factor: 3.850

3.  From GWAS to drug screening: repurposing antipsychotics for glioblastoma.

Authors:  Wei-Zhi Lin; Yen-Chun Liu; Meng-Chang Lee; Chi-Tun Tang; Gwo-Jang Wu; Yu-Tien Chang; Chi-Ming Chu; Chia-Yang Shiau
Journal:  J Transl Med       Date:  2022-02-04       Impact factor: 5.531

4.  Defined factors to reactivate cell cycle activity in adult mouse cardiomyocytes.

Authors:  Justin Judd; Jonathan Lovas; Guo N Huang
Journal:  Sci Rep       Date:  2019-12-11       Impact factor: 4.379

5.  First-in-human DR5 PET reveals insufficient DR5 expression in patients with gastrointestinal cancer.

Authors:  Shujing Wang; Hua Zhu; Yingjie Li; Jin Ding; Feng Wang; Lixin Ding; Xinyu Wang; Jun Zhao; Yan Zhang; Yunfeng Yao; Tong Zhou; Nan Li; Aiwen Wu; Zhi Yang
Journal:  J Immunother Cancer       Date:  2021-07       Impact factor: 13.751

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.